131 related articles for article (PubMed ID: 38282187)
1. Fanconi Anemia Complementary Group A (FANCA) Facilitates the Occurrence and Progression of Liver Hepatocellular Carcinoma.
Huang FD; Zhong YP; Sun GY; Xu QJ; Xing ZY; Chen KH; Liao LS; Dong MY
Dig Dis Sci; 2024 Mar; 69(3):1035-1054. PubMed ID: 38282187
[TBL] [Abstract][Full Text] [Related]
2. Exploration of YBX1 role in the prognostic value and immune characteristics by single-cell and bulk sequencing analysis for liver hepatocellular carcinoma.
Zhang Q; Zhu B; Yang H; Li F; Qu Y; Lu L; Zhang Q
J Gene Med; 2024 Mar; 26(3):e3680. PubMed ID: 38448368
[TBL] [Abstract][Full Text] [Related]
3. PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma.
Jin W; Wang G; Dong M; Wang X
Eur J Med Res; 2024 Mar; 29(1):177. PubMed ID: 38494503
[TBL] [Abstract][Full Text] [Related]
4. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis unveils ECM signatures and pathways driving hepatocellular carcinoma progression: A multi-omics approach and prognostic model development.
Liu Z; Zhao P
J Cell Mol Med; 2024 Apr; 28(8):e18230. PubMed ID: 38568083
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of DEPDC1B as an Independent Early Diagnostic and Prognostic Biomarker in Liver Hepatocellular Carcinoma.
Fan X; Wen J; Bao L; Gao F; Li Y; He D
Front Genet; 2021; 12():681809. PubMed ID: 35095994
[TBL] [Abstract][Full Text] [Related]
7. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
[TBL] [Abstract][Full Text] [Related]
8. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Dai Q; Zhu J; Yang J; Zhang CY; Yang WJ; Pan BS; Yang XR; Guo W; Wang BL
Curr Stem Cell Res Ther; 2024 Mar; ():. PubMed ID: 38561604
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma.
Kui XY; Gao Y; Liu XS; Zeng J; Yang JW; Zhou LM; Liu XY; Zhang Y; Zhang YH; Pei ZJ
Front Oncol; 2022; 12():809847. PubMed ID: 35957868
[TBL] [Abstract][Full Text] [Related]
10. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X
Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866
[TBL] [Abstract][Full Text] [Related]
11. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
Yan C; Niu Y; Ma L; Tian L; Ma J
J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876
[TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker:
Lai T; Peng T; Li J; Jiang Y; Liu K; Yu W; Yao N; Hu Y; Cao M; Liang J
Transl Cancer Res; 2023 May; 12(5):1145-1164. PubMed ID: 37304536
[TBL] [Abstract][Full Text] [Related]
13. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular Carcinoma.
Chen G; Mo S; Yuan D
Biomed Res Int; 2021; 2021():9911784. PubMed ID: 34195286
[TBL] [Abstract][Full Text] [Related]
14. Systematic Analyses of the Role of the Reader Protein of
Shao XY; Dong J; Zhang H; Wu YS; Zheng L
Front Mol Biosci; 2020; 7():577460. PubMed ID: 33344502
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic, prognostic, drug sensitivity and ceRNA internet of
Li X; Pan Y; Feng S; Xing W; Lin B; Li W; Li M; Zhu M
Transl Cancer Res; 2024 Feb; 13(2):594-612. PubMed ID: 38482448
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
17. FANCA facilitates G1/S cell cycle advancement, proliferation, migration and invasion in gastric cancer.
Wang W; Baral S; Liu B; Sun Q; Wang L; Ren J; Tang D; Wang D
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; ():. PubMed ID: 38682160
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma.
He D; Zhang X; Tu J
Cancer Med; 2020 Dec; 9(23):8782-8800. PubMed ID: 32978904
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the correlation of the pan-cancer gene HAUS5 with prognosis and immune infiltration in liver cancer.
Zhang W; Yang C; Hu Y; Yi K; Xiao W; Xu X; Chen Z
Sci Rep; 2023 Feb; 13(1):2409. PubMed ID: 36765148
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
Han X; Long W; Liu Y; Xu J
Front Surg; 2022; 9():985034. PubMed ID: 36338652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]